4:20 PM ET
10-Q
Financial Results
Johnson & Johnson Q3 2026 Results: Net Income $210M, Down 95.9% YoY
Johnson & Johnson reported 2,407,310,266 shares of common stock outstanding as of October 15, 2026. The filing outlines the company's financial results for the fiscal third quarter and nine months ended September 27, 2026, while highlighting strategic risks including the planned separation of its Orthopaedics business.
- Key figure
- Net income $210M · -95.9% YoY